Andrew Kada has over 10 years of experience in biomedical research, with a focus on oncology medicines. Currently, they work at Pfizer as a Manager in Portfolio Planning & Intelligence for the Oncology Division, overseeing early-stage to marketed R&D planning and supporting multiple oncology assets. Previously, they held leadership roles at Seagen, earning two Seagen Impact Awards for their contributions to clinical contracts management and program management. Andrew also has experience in grant and contract analysis from their time at several institutions, including Children's National Health System and American University. They are pursuing further education at Stevens Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices